Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.

Author: DyerMatthew J, HalpinDavid M G, SteinKen

Paper Details 
Original Abstract of the Article :
Ciclesonide is a new inhaled corticosteroids licensed for the prophylactic treatment of persistent asthma in adults. Currently beclomethasone dipropionate, budesonide and fluticasone propionate are the most commonly prescribed inhaled corticosteroids for the treatment of asthma but there has been no...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525171/

データ提供:米国国立医学図書館(NLM)

Inhaled Corticosteroids: Finding the Right Oasis in the Desert of Asthma

Asthma, like a sandstorm, can make it difficult to breathe. Inhaled corticosteroids are like oases in the desert, offering relief and control. This study focuses on ciclesonide, a relatively new player in the inhaled corticosteroid game. Researchers wanted to see how ciclesonide stacks up against its more established counterparts, such as budesonide, beclomethasone, and fluticasone, in managing chronic asthma.

Ciclesonide: A New Oasis in the Desert of Asthma

This systematic review revealed that ciclesonide holds its own against its more seasoned competitors. The researchers found that ciclesonide is a promising treatment option for chronic asthma, offering similar effectiveness and safety profiles. This finding adds another oasis to the landscape of asthma management, giving patients a wider range of options to manage their condition.

Managing Asthma: Choosing the Right Oasis

Finding the right inhaled corticosteroid can be crucial for managing asthma. With ciclesonide emerging as a viable option, individuals with chronic asthma now have more choices to find the oasis that best suits their needs. This research encourages patients to work with their healthcare providers to determine the most effective treatment strategy for managing their asthma.

Dr. Camel's Conclusion

This systematic review offers a refreshing perspective on inhaled corticosteroids, highlighting the effectiveness of ciclesonide as a viable treatment option for chronic asthma. As we continue to explore and understand the nuances of this desert disease, it's crucial to have a variety of oases available to ensure optimal care for those who navigate the unpredictable terrain of asthma.
Date :
  1. Date Completed 2006-08-09
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16753053

DOI: Digital Object Identifier

PMC1525171

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.